cephradine | 			
Cefradine | 
				
38821-53-3 | 			
Cephradin | 
				
Anspor | 			
Sefril | 
				
Velosef | 			
Cefradina | 
				
Cefradinum | 			
Eskacef | 
				
Cefradin | 			
SQ 11436 | 
				
SQ-11436 | 			
UNII-9YA6SX5S4D | 
				
7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid | 			
CHEBI:3547 | 
				
(6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | 			
(6R,7R)-7-(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetylamino-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid | 
				
9YA6SX5S4D | 			
(6R,7R)-7-{(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetylamino}-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid | 
				
CED | 			
NCGC00183036-01 | 
				
DSSTox_CID_2785 | 			
Cefradinum INN-Latin | 
				
Cephradine USAN:BAN | 			
DSSTox_RID_76729 | 
				
Cefradina INN-Spanish | 			
DSSTox_GSID_22785 | 
				
(6R,7R)-7-(2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid | 			
(7R)-7-(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetylamino-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid | 
				
Cekodin | 			
Megacef | 
				
Velocef | 			
Megace f | 
				
SKF D 39304 | 			
(6R,7R)-7-((R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid | 
				
Cephradine (USP) | 			
Velosef (TN) | 
				
VELOSEF 125" | 			
VELOSEF 250" | 
				
VELOSEF 500 | 			
 Anspor (TN) | 
				
CAS-38821-53-3 | 			
HSDB 3216 | 
				
Cefradine (JAN/INN) | 			
EINECS 254-137-8 | 
				
BRN 6075388 | 			
Infexin | 
				
Cephradine,(S) | 			
Cefradine INN | 
				
(6R,7R)-7-((R)-2-amino-2-(cyclohexa-1,4-dienyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid | 			
SK&F D-39304 | 
				
SK-D-39304 | 			
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))- | 
				
7-(D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-caboxylic acid | 			
SQ-22022 | 
				
Epitope ID:116210 | 			
SCHEMBL3244 | 
				
CHEMBL1604 | 			
DivK1c_000739 | 
				
AMY500 | 			
GTPL4830 | 
				
DTXSID4022785 | 			
HMS502E21 | 
				
KBio1_000739 | 			
NINDS_000739 | 
				
BCPP000291 | 			
SQ 22022 DIHYDRATE | 
				
HY-B1156 | 			
ZINC3830515 | 
				
Tox21_113488 | 			
BDBM50370585 | 
				
MFCD00865048 | 			
s4671 | 
				
AKOS015961130 | 			
Tox21_113488_1 | 
				
AC-1409 | 			
BCP9000506 | 
				
CCG-208520 | 			
CS-4608 | 
				
DB01333 | 			
NSC 756672 | 
				
IDI1_000739 | 			
Cefradine 100 microg/mL in Acetonitrile | 
				
NCGC00183036-02 | 			
NCGC00263658-01 | 
				
7beta-(2R)-2-(cyclohexa-1,4-dienyl)-2-phenylacetamido-3-methyl-3,4-didehydrocepham-4-carboxylic acid | 			
AS-75158 | 
				
C06897 | 			
C74975 | 
				
D00264 | 			
821C533 | 
				
Q2734674 | 			
Cefradine, European Pharmacopoeia (EP) Reference Standard | 
				
UNII-F1BC02I72W component RDLPVSKMFDYCOR-UEKVPHQBSA-N | 			
Cefradine for peak identification, European Pharmacopoeia (EP) Reference Standard | 
				
5-Thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid,7-(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetylamino-3-methyl-8-oxo-,(6R,7R)- | 			
5-Thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid,7-(2R)-amino-1,4-cyclohexadien-1-ylacetylamino-3-methyl-8-oxo-,(6R,7R)- |